Potential of old-generation antibiotics to address current need for new antibiotics

@article{Falagas2008PotentialOO,
  title={Potential of old-generation antibiotics to address current need for new antibiotics},
  author={Matthew E. Falagas and Alexandros Grammatikos and Argyris S Michalopoulos},
  journal={Expert Review of Anti-infective Therapy},
  year={2008},
  volume={6},
  pages={593 - 600}
}
Despite the constantly increasing need for new antimicrobial agents, antibiotic drug discovery and development seem to have greatly decelerated in recent years. Presented with the significant problem of advancing antimicrobial resistance, the global scientific community has attempted to find alternative solutions; one of the most promising ones is the evaluation and use of old antibiotic compounds. Due to the low-level use of many of the old antibiotic compounds, these have remained active… 
Tetracycline and Chloramphenicol Efficiency Against Selected Biofilm Forming Bacteria
TLDR
Testing the effects of older antibiotics on biofilms may supply useful information in addition to standard in vitro testing, particularly in diseases where biofilm formation is involved in the pathogenesis.
Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.
The introduction of effective antibacterial therapies for infectious diseases in the mid-20th century completely revolutionized clinical practices and helped to facilitate the development of modern
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
TLDR
The mechanism of action and molecular mechanisms for the development of fosfomycin resistance, including the modification of the antibiotic target, reduced antibiotic uptake and antibiotic inactivation are analysed and the role of each pathway in clinical isolates is described.
Advances in MRSA drug discovery: where are we and where do we need to be?
TLDR
The FDA-approved drugs to treat MRSA infections, the drugs in clinical trials, and the drug leads for MRSA and related Gram-positive bacterial infections are summarized.
Optimising use of fosfomycin against multidrug-resistant Pseudomonas aeruginosa
TLDR
A range of PD properties for fosfomycin against P. aeruginosa are established, showing for the first time, as far as the authors are aware, the presence of fosFomycin heteroresistance and that the antimicrobial activity of fOSfomyin is time-dependent.
Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant Enterobacteriaceae
TLDR
In a murine peritoneal infection model, AZT in combination with colistin showed augmented activities of both drugs in the treatment of NDM-1 K. pneumoniae and mcr-1 E. coli infections.
Frequency of Spontaneous Resistance to Fosfomycin Combined with Different Antibiotics in Pseudomonas aeruginosa
TLDR
The results suggest that the combinations of fosfomycin with ceftazidime or imipenem are less appropriate, in terms of probability of mutant occurrence, than those with tobramycin or ciprofloxacin.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 85 REFERENCES
Novel approaches to developing new antibiotics for bacterial infections
TLDR
Possible new ways to discover novel antibiotics are reviewed, including new discovery routes that have given rise to compounds that are in preclinical development, but, with one exception, have not yet entered clinical trials.
Pharmacokinetics and pharmacodynamics of antimicrobials.
  • G. Drusano
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2007
TLDR
The rate of discovery of new antibiotics has been declining, coincident with the explosion in the number of multidrug-resistant organisms in both the community and hospital environments, which makes the identification of optimal regimens that will result in good clinical and microbiological outcomes important.
Use of genomics to select antibacterial targets.
  • M. Pucci
  • Biology
    Biochemical pharmacology
  • 2006
Safety and efficacy of glycopeptide antibiotics.
TLDR
A global overview of the efficacy and safety of glycopeptide antibiotics currently in use is provided, as background to understanding the need for and potential roles of new agents of this class.
Glycopeptides: Update on an old successful antibiotic class.
New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors.
  • I. Chopra
  • Biology
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
  • 2002
Old antibiotics for infections in critically ill patients
TLDR
The effectiveness and safety of older antibiotics when used in the treatment of infections of critically ill patients are highlighted, and fosfomycin and chloramphenicol have a wide antimicrobial spectrum and may have an expanded role in the antimicrobial arsenal.
...
1
2
3
4
5
...